Shikonin inhibits the cell viability, adhesion, invasion and migration of the human gastric cancer cell line MGC-803 via the Toll-like receptor 2/nuclear factor-kappa B pathway

Journal of Pharmacy and Pharmacology

Volumn 67, Issue 8, 2015, Pages 1143-1155

  Liu, Ji Ping ^a,b   Liu, Dan ^a   Gu, Jun Fei ^a   Zhu, Mao Mao ^a   Cui, Li ^a  

^a KEY LABORATORY OF NEW DRUG DELIVERY SYSTEM OF CHINESE MATERIA MEDICA   (China)

^b SHAANXI UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

gastric cancer; invasion; migratory; Shikonin; toll like receptor 2

Indexed keywords

ANTIBODY; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; GELATINASE A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MATRILYSIN; SHIKONIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 2 ANTIBODY; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; NAPHTHOQUINONE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL VIABILITY; CONTROLLED STUDY; DRUG POTENTIATION; GASTRIC CANCER CELL LINE; HUMAN; HUMAN CELL; IC50; PROTEIN EXPRESSION; STOMACH CANCER; BIOSYNTHESIS; CELL SURVIVAL; DRUG EFFECTS; LITHOSPERMUM; METABOLISM; PATHOPHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL ADHESION; CELL LINE, TUMOR; CELL SURVIVAL; HUMANS; INHIBITORY CONCENTRATION 50; LITHOSPERMUM; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 7; NAPHTHOQUINONES; NF-KAPPA B; REAL-TIME POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; TOLL-LIKE RECEPTOR 2;

EID: 84936998537     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/jphp.12402     Document Type: Article

References (40)

1. Fanelli MF, et al. Factors correlated with peritoneal carcinomatosis and survival in patients with gastric cancer treated at a single institution in Brazil. Int J Clin Oncol 2009; 14: 326-331.
2. Kinjo T, et al. Histologic and immunohistochemical analyses of α-fetoprotein-producing cancer of the stomach. Am J Surg Pathol 2012; 36: 56-65.
3. Streit M, et al. Adhesion receptors in malignant transformation and dissemination of gastrointestinal tumors. J Mol Med (Berl) 1996; 74: 253-268.
4. Koizumi K, et al. Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response. Cancer Sci 2007; 98: 1652-1658.
5. Lukaszewicz-Zając M, et al. Gastric cancer-The role of matrix metalloproteinases in tumor progression. Clin Chim Acta 2011; 412: 1725-1730.
6. McCormack W, et al. Toll-like receptor 2: therapeutic target for gastric carcinogenesis. Oncotarget 2012; 3: 1260-1261.
7. de Oliveira JG, et al. Profiles of gene polymorphisms in cytokines and toll-like receptors with higher risk for gastric cancer. Dig Dis Sci 2013; 58: 978-988.
8. de Oliveira JG, et al. Polymorphisms of the TLR2 and TLR4 genes are associated with risk of gastric cancer in a Brazilian population. World J Gastroenterol 2012; 18: 1235-1242.
9. Paolillo R, et al. Induction of VEGF and MMP-9 expression by toll-like receptor 2/4 in human endothelial cells infected with Chlamydia pneumoniae. Int J Immunopathol Pharmacol 2012; 25: 377-386.
10. Roderfeld M, et al. Induction of matrix metalloproteinases and TLR2 and 6 in murine colon after oral exposure to Mycobacterium avium subsp. Paratuberculosis. Microbes Infect 2012; 14: 545-553.
11. Wang H, et al. Shikonin attenuates lung cancer cell adhesion to extracellular matrix and metastasis by inhibiting integrin β1 expression and the ERK1/2 signaling pathway. Toxicology 2013; 308: 104-112.
12. Yang Q, et al. Shikonin inhibits thyroid cancer cell growth and invasiveness through targeting major signaling pathways. J Clin Endocrinol Metab 2013; 98: E1909-E1917.
13. Wang HB, et al. Mechanisms of (2-methyl-n-butyl) shikonin induced apoptosis of gastric cancer SGC-7901 cells. Yao Xue Xue Bao 2012; 47: 816-821.
14. Min R, et al. Shikonin inhibits tumor invasion via down-regulation of NF-κB-mediated MMP-9 expression in human ACC-M cells. Oral Dis 2011; 17: 362-369.
15. Shang Y, et al. Cucurbitacin-B inhibits neuroblastoma cell proliferation through up-regulation of PTEN. Eur Rev Med Pharmacol Sci 2014; 18: 3209-3303.
16. Lu M, et al. Alternation of adriamycin penetration kinetics in MCF-7 cells from 2D to 3D culture based on P-gp expression through the Chk2/p53/NF-κB pathway. Biochem Pharmacol 2015; 93: 210-220.
17. Lee HG, et al. Salinomycin inhibited cell proliferation and induced apoptosis in human uterine leiomyoma cells. Obstet Gynecol Sci 2014; 57: 501-506.
18. Cheng XD, et al. Astragaloside IV inhibits migration and invasion in human lung cancer A549 cells via regulating PKC-α-ERK1/2-NF-κB pathway. Int Immunopharmacol 2014; 23: 304-313.
19. Nelson MT, et al. Preferential, enhanced breast cancer cell migration on biomimetic electrospun nanofiber 'cell highways'. BMC Cancer 2014; 10: 825.
20. Banyard J, et al. Identification of genes regulating migration and invasion using a new model of metastatic prostate cancer. BMC Cancer 2014; 14: 387.
21. Guo H, et al. The regulation of Toll-like receptor 2 by miR-143 suppresses the invasion and migration of a subset of human colorectal carcinoma cells. Mol Cancer 2013; 12: 77-86.
22. Zhang DY, et al. Lipopolysaccharide (LPS) of Porphyromonas gingivalis induces IL-1beta, TNF-alpha and IL-6 production by THP-1 cells in a way different from that of Escherichia coli LPS. Innate Immun 2008; 14: 99-107.
23. Haddad JJ, et al. Nuclear factor-kappa B-independent regulation of lipopolysaccharide-mediated interleukin-6 biosynthesis. Biochem Biophys Res Commun 2002; 291: 1045-1051.
24. Lee MJ, et al. Shikonin time-dependently induced necrosis or apoptosis in gastric cancer cells via generation of reactive oxygen species. Chem Biol Interact 2014; 211: 44-53.
25. Wei PL, et al. Shikonin suppresses the migratory ability of hepatocellular carcinoma cells. J Agric Food Chem 2013; 61: 8191-8197.
26. Fu Z, et al. The anti-tumor effect of shikonin on osteosarcoma by inducing RIP1 and RIP3 dependent necroptosis. BMC Cancer 2013; 13: 580.
27. Zhang B, et al. The critical role of redox homeostasis in shikonin-induced HL-60 cell differentiation via unique modulation of the Nrf2/ARE pathway. Oxid Med Cell Longev 2012; 2012: 781516.
28. Li X, et al. Loss of MTUS1 in gastric cancer promotes tumor growth and metastasis. Neoplasma 2014; 61: 128-135.
29. Tavazoie SF, et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 2008; 451: 147-152.
30. Song EJ, et al. Flagellin promotes the proliferation of gastric cancer cells via the Toll-like receptor 5. Int J Mol Med 2011; 28: 115-119.
31. Tye H, et al. STAT3-driven upregulation of TLR2 promotes gastric tumorigenesis independent of tumor inflammation. Cancer Cell 2012; 22: 466-478.
32. Zeng HM, et al. Genetic variants of toll-like receptor 2 and 5, helicobacter pylori infection, and risk of gastric cancer and its precursors in a chinese population. Cancer Epidemiol Biomarkers Prev 2011; 20: 2594-2602.
33. Kim SH, et al. Effect of Dracocephalum argunense on mast-cell-mediated hypersensitivity. Int Arch Allergy Immunol 2006; 139: 87-95.
34. Chen C, et al. Shikonin, a natural product from the root of Lithospermum erythrorhizon, is a cytotoxic DNA-binding agent. Eur J Pharm Sci 2013; 49: 18-26.
35. Liu J, et al. Proteasome inhibitor MG132 enhances the antigrowth and antimetastasis effects of radiation in human nonsmall cell lung cancer cells. Tumour Biol 2014; 35: 7531-7539.
36. Chen HY, et al. Upregulated ROS production induced by the proteasome inhibitor MG-132 on XBP1 gene expression and cell apoptosis in Tca-8113 cells. Biomed Pharmacother 2014; 68: 709-713.
37. Hong SW, et al. Matrix metalloproteinase-2 and -7 expression in colorectal cancer. J Korean Soc Coloproctol 2011; 27: 133-139.
38. Noh S, et al. MMP-2 as a putative biomarker for carcinomatosis in gastric cancer. Hepatogastroenterology 2011; 58: 2015-2019.
39. Chang IC, et al. Shikonin induces apoptosis through reactive oxygen species/extracellular signal-regulated kinase pathway in osteosarcoma cells. Biol Pharm Bull 2010; 33: 816-824.
40. Gong K, et al. Shikonin, a Chinese plant-derived naphthoquinone, induces apoptosis in hepatocellular carcinoma cells through reactive oxygen species: a potential new treatment for hepatocellular carcinoma. Free Radic Biol Med 2011; 51: 2259-2271.